Literature DB >> 10858214

Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread.

M Allewelt1, F T Coleman, M Grout, G P Priebe, G B Pier.   

Abstract

Pseudomonas aeruginosa is the nosocomial bacterial pathogen most commonly isolated from the respiratory tract. Animal models of this infection are extremely valuable for studies of virulence and immunity. We thus evaluated the utility of a simple model of acute pneumonia for analyzing P. aeruginosa virulence by characterizing the course of bacterial infection in BALB/c mice following application of bacteria to the nares of anesthetized animals. Bacterial aspiration into the lungs was rapid, and 67 to 100% of the inoculum could be recovered within minutes from the lungs, with 0.1 to 1% of the inoculum found intracellularly shortly after infection. At later time points up to 10% of the bacteria were intracellular, as revealed by gentamicin exclusion assays on single-cell suspensions of infected lungs. Expression of exoenzyme U (ExoU) by P. aeruginosa is associated with a cytotoxic effect on epithelial cells in vitro and virulence in animal models. Insertional mutations in the exoU gene confer a noncytotoxic phenotype on mutant strains and decrease virulence for animals. We used the model of acute pneumonia to determine whether introduction of the exoU gene into noncytotoxic strains of P. aeruginosa lacking this gene affected virulence. Seven phenotypically noncytotoxic P. aeruginosa strains were transformed with pUCP19exoUspcU which carries the exoU gene and its associated chaperone. Three of these strains became cytotoxic to cultured epithelial cells in vitro. These strains all secreted ExoU, as confirmed by detection of the ExoU protein with specific antisera. The 50% lethal dose of exoU-expressing strains was significantly lower for all three P. aeruginosa isolates carrying plasmid pUCP19exoUspcU than for the isogenic exoU-negative strains. mRNA specific for ExoU was readily detected in the lungs of animals infected with the transformed P. aeruginosa strains. Introduction of the exoU gene confers a cytotoxic phenotype on some, but not all, otherwise-noncytotoxic P. aeruginosa strains and, for recombinant strains that could express ExoU, there was markedly increased virulence in a murine model of acute pneumonia and systemic spread.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858214      PMCID: PMC101680          DOI: 10.1128/IAI.68.7.3998-4004.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Distribution, clearance, and mortality of environmental pseudomonads in mice upon intranasal exposure.

Authors:  S E George; M J Kohan; D A Whitehouse; J P Creason; C Y Kawanishi; R L Sherwood; L D Claxton
Journal:  Appl Environ Microbiol       Date:  1991-08       Impact factor: 4.792

2.  The role of exoenzyme S in infections with Pseudomonas aeruginosa.

Authors:  T I Nicas; J Bradley; J E Lochner; B H Iglewski
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

3.  Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia.

Authors:  K Kurahashi; O Kajikawa; T Sawa; M Ohara; M A Gropper; D W Frank; T R Martin; J P Wiener-Kronish
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

4.  Penetration of clinical isolates of Pseudomonas aeruginosa through MDCK epithelial cell monolayers.

Authors:  Y Hirakata; B B Finlay; D A Simpson; S Kohno; S Kamihira; D P Speert
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

5.  Predominant pathogens in hospital infections.

Authors:  W R Jarvis; W J Martone
Journal:  J Antimicrob Chemother       Date:  1992-04       Impact factor: 5.790

6.  Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System.

Authors:  S N Banerjee; T G Emori; D H Culver; R P Gaynes; W R Jarvis; T Horan; J R Edwards; J Tolson; T Henderson; W J Martone
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

7.  Role of Pseudomonas aeruginosa pili in acute pulmonary infection.

Authors:  H Tang; M Kays; A Prince
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

8.  Structure of an extracellular cross-reactive polysaccharide from Pseudomonas aeruginosa immunotype 4.

Authors:  N A Kocharova; Y A Knirel; A S Shashkov; N K Kochetkov; G B Pier
Journal:  J Biol Chem       Date:  1988-08-15       Impact factor: 5.157

9.  Pulmonary clearance and inflammatory response in C3H/HeJ mice after intranasal exposure to Pseudomonas spp.

Authors:  S E George; M J Kohan; M I Gilmour; M S Taylor; H G Brooks; J P Creason; L D Claxton
Journal:  Appl Environ Microbiol       Date:  1993-11       Impact factor: 4.792

10.  Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury.

Authors:  I Kudoh; J P Wiener-Kronish; S Hashimoto; J F Pittet; D Frank
Journal:  Am J Physiol       Date:  1994-11
View more
  88 in total

1.  CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation.

Authors:  Torsten H Schroeder; Martin M Lee; Patrick W Yacono; Carolyn L Cannon; A Alev Gerçeker; David E Golan; Gerald B Pier
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

2.  Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia.

Authors:  Weihui Wu; Jin Huang; Biyan Duan; David C Traficante; Haeyeon Hong; Martina Risech; Stephen Lory; Gregory P Priebe
Journal:  Am J Respir Crit Care Med       Date:  2012-06-21       Impact factor: 21.405

3.  Molecular cloning and expression of the C-terminal domain of mouse NTE-related esterase.

Authors:  Ping-An Chang; Ding-Xin Long; Yi-Jun Wu
Journal:  Mol Cell Biochem       Date:  2007-08-03       Impact factor: 3.396

4.  Characterization of phospholipase activity of the Pseudomonas aeruginosa type III cytotoxin, ExoU.

Authors:  Hiromi Sato; Jimmy B Feix; Cecilia J Hillard; Dara W Frank
Journal:  J Bacteriol       Date:  2005-02       Impact factor: 3.490

5.  A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells.

Authors:  Shira D P Rabin; Jeffrey L Veesenmeyer; Kathryn T Bieging; Alan R Hauser
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

6.  Functional regions of the Pseudomonas aeruginosa cytotoxin ExoU.

Authors:  Shira D P Rabin; Alan R Hauser
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

7.  Type III secretion-dependent modulation of innate immunity as one of multiple factors regulated by Pseudomonas aeruginosa RetS.

Authors:  Irandokht Zolfaghar; David J Evans; Reza Ronaghi; Suzanne M J Fleiszig
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

8.  In vitro assays to monitor the activity of Pseudomonas aeruginosa Type III secreted proteins.

Authors:  Stephanie L Rolsma; Dara W Frank
Journal:  Methods Mol Biol       Date:  2014

Review 9.  Exploitation of eukaryotic subcellular targeting mechanisms by bacterial effectors.

Authors:  Stuart W Hicks; Jorge E Galán
Journal:  Nat Rev Microbiol       Date:  2013-05       Impact factor: 60.633

10.  Pseudomonas aeruginosa induces localized immunosuppression during pneumonia.

Authors:  Maureen H Diaz; Ciara M Shaver; John D King; Srinidhi Musunuri; Jeffrey A Kazzaz; Alan R Hauser
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.